TrialCancer prevention research (Philadelphia, Pa.)2013

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial.

Mahboobeh Safaeian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.